Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation - TachoSil, September 2, 2009

System Info - 104129  HE, JIE   02-Sep-2009 16:22:45  HEJ


Submission Type: Original Application   Submission ID:  125351/0    Office: OBRR  

Fibrin Sealant

Nycomed Danmark ApS          

Telecon Date/Time:  02-SEP-2009 12:00 AM                Initiated by FDA?  Yes

Communication Categorie(s):
Information Request

Author:  JIE HE

Telecon Summary:
Clarify issue related to PREA

FDA Participants:  
Kimberly Lindsey, Jie He

Non-FDA Participants:   

  • Camilla Wamberg, Regulatory Affairs Manager
  • Bettina Twile, Director, Regulatory
  • Kreesten Meldgaard Madsen, Medical Director
  • Vilhelm Tetens, Senior Int. Medical Advisor
  • Henrik Steen Andersen, Statistician
  • Susanne Munk, Senior Project Director
  • Kevin Johnson, US Agent for Nycomed

Trans-BLA Group: No

Related STNs:  

Related PMCs:  None

Telecon Body:
FDA: There is no specific statement found in the submission that specifically addresses PREA. During pre-BLA discussions, Nycomed agreed to address PREA in some fashion, but the BLA submission does not formally address studies intended to fulfill PREA requirements. The proposed labeling for TachoSil suggests that the study TC-019 (a pediatric study in liver surgery) is intended to support use of TachoSil in the pediatric population.

Nycomed: Although not specifically addressed PREA in the submission, the particular reference we used in the label is the TC-019 study (liver resection in children).

FDA: For clarification, the study Nycomed intends to use to address US PREA requirements is TC-019?

Nycomed: Correct.

FDA: Thank you for the clarification.




Page Last Updated: 05/04/2010
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English